ISRGIntuitive Surgical

$423.91-2.7% 1Y

Is it growing?

Excellent

Growing: revenue growing +21% year on year, earnings up +21% year on year, and operating margin widening (+2.5 points).

3 good
Revenue trend+21% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +16% a year.

Earnings trend+21% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+2.5 points operating

Trailing-twelve-month operating margin, 31.2% now against 28.7% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 87% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ISRG growing?

Intuitive Surgical has grown revenue 18% a year over three years and 16% a year over five, with earnings per share compounding at 30%.

+18%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+16%

Revenue growth, 5-year rate · +18% over three · growth has picked up over the last three years

Earnings per share, 3-year rate
+30%

Earnings per share, 3-year rate · revenue +18% · earnings outgrew revenue: margins or the share count worked for shareholders

Years of annual history on file
19

Years of annual history on file · FY2007 to FY2025, as filed

Details›
Revenue FY2021
$5.71B
Revenue FY2022
$6.22B
Revenue FY2023
$7.12B
Revenue FY2024
$8.35B
Revenue FY2025
$10.1B

Annual income statements as filed with the SEC.

On our screens:R&D leaders